STOCK TITAN

[144] Aehr Test Systems SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Aehr Test Systems (AEHR) filed Form 144 disclosing a proposed insider sale under SEC Rule 144.

  • Securities to be sold: 5,000 common shares.
  • Broker: Charles Schwab Corp., Westlake, TX.
  • Estimated market value: US $106,600 (implies ≈ $21.32 per share).
  • Sale window: on or about 25 Jul 2025 via NASDAQ.
  • Origin of shares: acquired 11 Jul 2023 as compensation from the issuer.
  • Shares outstanding: 29,771,410; planned sale equals ≈ 0.017 % of total.

No other sales during the past three months were reported. The filer attests to having no undisclosed material adverse information and acknowledges Rule 10b5-1 and anti-fraud obligations.

Aehr Test Systems (AEHR) ha presentato il Modulo 144 per comunicare una vendita proposta da un insider ai sensi della Regola 144 della SEC.

  • Titoli da vendere: 5.000 azioni ordinarie.
  • Intermediario: Charles Schwab Corp., Westlake, TX.
  • Valore di mercato stimato: 106.600 USD (circa 21,32 USD per azione).
  • Finestra di vendita: intorno al 25 luglio 2025 tramite NASDAQ.
  • Origine delle azioni: acquisite l'11 luglio 2023 come compenso dall'emittente.
  • Azioni in circolazione: 29.771.410; la vendita prevista corrisponde a circa lo 0,017% del totale.

Non sono state segnalate altre vendite negli ultimi tre mesi. Il dichiaratore conferma di non possedere informazioni materiali avverse non divulgate e riconosce gli obblighi previsti dalla Regola 10b5-1 e dalle norme anti-frode.

Aehr Test Systems (AEHR) presentó el Formulario 144 para revelar una venta propuesta por un insider conforme a la Regla 144 de la SEC.

  • Valores a vender: 5,000 acciones comunes.
  • Corredor: Charles Schwab Corp., Westlake, TX.
  • Valor de mercado estimado: 106,600 USD (aproximadamente 21.32 USD por acción).
  • Ventana de venta: alrededor del 25 de julio de 2025 a través de NASDAQ.
  • Origen de las acciones: adquiridas el 11 de julio de 2023 como compensación del emisor.
  • Acciones en circulación: 29,771,410; la venta planificada representa aproximadamente el 0.017% del total.

No se reportaron otras ventas en los últimos tres meses. El declarante certifica no poseer información material adversa no divulgada y reconoce las obligaciones de la Regla 10b5-1 y las normas antifraude.

Aehr Test Systems (AEHR)는 SEC 규칙 144에 따른 내부자 판매 예정 내용을 공개하는 Form 144를 제출했습니다.

  • 판매 예정 증권: 보통주 5,000주.
  • 중개인: Charles Schwab Corp., Westlake, TX.
  • 예상 시장 가치: 미화 106,600달러 (주당 약 21.32달러).
  • 판매 기간: 2025년 7월 25일경 NASDAQ을 통해 진행 예정.
  • 주식 출처: 2023년 7월 11일 발행사로부터 보상으로 취득.
  • 발행 주식 수: 29,771,410주; 예정된 판매는 전체의 약 0.017%에 해당.

최근 3개월 내 다른 판매 내역은 보고되지 않았습니다. 제출자는 미공개 중대한 부정적 정보가 없음을 확인하며, Rule 10b5-1 및 반부정행위 의무를 인지하고 있음을 인정합니다.

Aehr Test Systems (AEHR) a déposé le formulaire 144 révélant une vente envisagée par un initié conformément à la règle 144 de la SEC.

  • Valeurs mobilières à vendre : 5 000 actions ordinaires.
  • Intermédiaire : Charles Schwab Corp., Westlake, TX.
  • Valeur marchande estimée : 106 600 USD (soit environ 21,32 USD par action).
  • Période de vente : aux alentours du 25 juillet 2025 via NASDAQ.
  • Origine des actions : acquises le 11 juillet 2023 en tant que rémunération de l’émetteur.
  • Actions en circulation : 29 771 410 ; la vente prévue représente environ 0,017 % du total.

Aucune autre vente n’a été déclarée au cours des trois derniers mois. Le déclarant certifie ne pas détenir d’informations défavorables importantes non divulguées et reconnaît les obligations liées à la règle 10b5-1 ainsi qu’aux règles anti-fraude.

Aehr Test Systems (AEHR) hat das Formular 144 eingereicht, um einen geplanten Insider-Verkauf gemäß SEC-Regel 144 offenzulegen.

  • Zu verkaufende Wertpapiere: 5.000 Stammaktien.
  • Broker: Charles Schwab Corp., Westlake, TX.
  • Geschätzter Marktwert: 106.600 USD (entspricht ca. 21,32 USD pro Aktie).
  • Verkaufszeitraum: um den 25. Juli 2025 über NASDAQ.
  • Herkunft der Aktien: am 11. Juli 2023 als Vergütung vom Emittenten erhalten.
  • Ausstehende Aktien: 29.771.410; der geplante Verkauf entspricht ca. 0,017 % des Gesamtbestands.

In den letzten drei Monaten wurden keine weiteren Verkäufe gemeldet. Der Meldende bestätigt, keine nicht offengelegten wesentlichen nachteiligen Informationen zu besitzen und erkennt die Verpflichtungen aus Regel 10b5-1 sowie Anti-Betrugs-Vorschriften an.

Positive
  • None.
Negative
  • Insider plans to sell shares, which can be interpreted as a mild negative signal despite small size (≈ 0.017 % of shares outstanding).

Insights

TL;DR: Small insider sale (5k shares) worth $107k; immaterial to float but marginally negative sentiment.

The filing signals intent to dispose of 0.017 % of AEHR’s outstanding shares—financially negligible relative to the 29.8 M share base. Because the stock was acquired as compensation, the sale may represent routine diversification rather than a valuation call. No aggregation with other insiders is required, and the seller affirms no undisclosed adverse information. From a liquidity standpoint, the trade should have minimal market impact; however, any insider sale can be viewed cautiously by investors, especially against a volatile semiconductor-equipment backdrop.

Aehr Test Systems (AEHR) ha presentato il Modulo 144 per comunicare una vendita proposta da un insider ai sensi della Regola 144 della SEC.

  • Titoli da vendere: 5.000 azioni ordinarie.
  • Intermediario: Charles Schwab Corp., Westlake, TX.
  • Valore di mercato stimato: 106.600 USD (circa 21,32 USD per azione).
  • Finestra di vendita: intorno al 25 luglio 2025 tramite NASDAQ.
  • Origine delle azioni: acquisite l'11 luglio 2023 come compenso dall'emittente.
  • Azioni in circolazione: 29.771.410; la vendita prevista corrisponde a circa lo 0,017% del totale.

Non sono state segnalate altre vendite negli ultimi tre mesi. Il dichiaratore conferma di non possedere informazioni materiali avverse non divulgate e riconosce gli obblighi previsti dalla Regola 10b5-1 e dalle norme anti-frode.

Aehr Test Systems (AEHR) presentó el Formulario 144 para revelar una venta propuesta por un insider conforme a la Regla 144 de la SEC.

  • Valores a vender: 5,000 acciones comunes.
  • Corredor: Charles Schwab Corp., Westlake, TX.
  • Valor de mercado estimado: 106,600 USD (aproximadamente 21.32 USD por acción).
  • Ventana de venta: alrededor del 25 de julio de 2025 a través de NASDAQ.
  • Origen de las acciones: adquiridas el 11 de julio de 2023 como compensación del emisor.
  • Acciones en circulación: 29,771,410; la venta planificada representa aproximadamente el 0.017% del total.

No se reportaron otras ventas en los últimos tres meses. El declarante certifica no poseer información material adversa no divulgada y reconoce las obligaciones de la Regla 10b5-1 y las normas antifraude.

Aehr Test Systems (AEHR)는 SEC 규칙 144에 따른 내부자 판매 예정 내용을 공개하는 Form 144를 제출했습니다.

  • 판매 예정 증권: 보통주 5,000주.
  • 중개인: Charles Schwab Corp., Westlake, TX.
  • 예상 시장 가치: 미화 106,600달러 (주당 약 21.32달러).
  • 판매 기간: 2025년 7월 25일경 NASDAQ을 통해 진행 예정.
  • 주식 출처: 2023년 7월 11일 발행사로부터 보상으로 취득.
  • 발행 주식 수: 29,771,410주; 예정된 판매는 전체의 약 0.017%에 해당.

최근 3개월 내 다른 판매 내역은 보고되지 않았습니다. 제출자는 미공개 중대한 부정적 정보가 없음을 확인하며, Rule 10b5-1 및 반부정행위 의무를 인지하고 있음을 인정합니다.

Aehr Test Systems (AEHR) a déposé le formulaire 144 révélant une vente envisagée par un initié conformément à la règle 144 de la SEC.

  • Valeurs mobilières à vendre : 5 000 actions ordinaires.
  • Intermédiaire : Charles Schwab Corp., Westlake, TX.
  • Valeur marchande estimée : 106 600 USD (soit environ 21,32 USD par action).
  • Période de vente : aux alentours du 25 juillet 2025 via NASDAQ.
  • Origine des actions : acquises le 11 juillet 2023 en tant que rémunération de l’émetteur.
  • Actions en circulation : 29 771 410 ; la vente prévue représente environ 0,017 % du total.

Aucune autre vente n’a été déclarée au cours des trois derniers mois. Le déclarant certifie ne pas détenir d’informations défavorables importantes non divulguées et reconnaît les obligations liées à la règle 10b5-1 ainsi qu’aux règles anti-fraude.

Aehr Test Systems (AEHR) hat das Formular 144 eingereicht, um einen geplanten Insider-Verkauf gemäß SEC-Regel 144 offenzulegen.

  • Zu verkaufende Wertpapiere: 5.000 Stammaktien.
  • Broker: Charles Schwab Corp., Westlake, TX.
  • Geschätzter Marktwert: 106.600 USD (entspricht ca. 21,32 USD pro Aktie).
  • Verkaufszeitraum: um den 25. Juli 2025 über NASDAQ.
  • Herkunft der Aktien: am 11. Juli 2023 als Vergütung vom Emittenten erhalten.
  • Ausstehende Aktien: 29.771.410; der geplante Verkauf entspricht ca. 0,017 % des Gesamtbestands.

In den letzten drei Monaten wurden keine weiteren Verkäufe gemeldet. Der Meldende bestätigt, keine nicht offengelegten wesentlichen nachteiligen Informationen zu besitzen und erkennt die Verpflichtungen aus Regel 10b5-1 sowie Anti-Betrugs-Vorschriften an.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many AEHR shares are being sold under this Form 144?

5,000 common shares are slated for sale.

What is the estimated market value of the proposed AEHR share sale?

Approximately $106,600 based on the filing.

When is the planned sale date for AEHR shares?

On or about July 25, 2025.

What percentage of AEHR’s outstanding shares does the sale represent?

Roughly 0.017 % of the 29,771,410 shares outstanding.

Why were the AEHR shares originally acquired?

They were received on July 11, 2023 as compensation from the issuer.

Which broker will handle the transaction?

Charles Schwab Corp. is listed as the executing broker.
Aehr Test Sys

NASDAQ:AEHR

AEHR Rankings

AEHR Latest News

AEHR Latest SEC Filings

AEHR Stock Data

662.67M
27.99M
5.06%
72.02%
24.14%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
FREMONT